ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM

The Lancet

Volumn 330, Issue 8567, 1987, Pages 1057-1058

  Radomski, M W ^a   Palmer, R M J ^a   Moncada, S ^a  

^a WELLCOME RESEARCH LABORATORIES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

BLOOD AND HEMOPOIETIC SYSTEM; HUMAN; HUMAN CELL; THROMBOCYTE ADHESION;

ANIMAL; ASPIRIN; BIOLOGICAL PRODUCTS; BRADYKININ; CATTLE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HEMOGLOBINS; HUMAN; INDIUM RADIOISOTOPES; NITRIC OXIDE; ORGANOMETALLIC COMPOUNDS; OXYQUINOLINE; PLATELET ADHESIVENESS; STIMULATION, CHEMICAL; SUPEROXIDE DISMUTASE; THROMBIN;

EID: 0023200487     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(87)91481-4     Document Type: Article

References (13)

1. EDRF
2. Prostacyclin and endothelium-derived relaxing factor: biological interactions and significance
3. Release of nitric oxide accounts for the biological activity of endothelium-derived relaxing factor
4. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets
5. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide
6. 2 mechanisms in vivo and in vitro
7. Release of endothelium-derived relaxing factor from human umbilical veins
8. The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobin
9. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase
10. An enzyme isolated from artenes transforms prostacyclin endoperoxides to an unstable substance that inhibits platelet aggregation
11. 2)-addition for preparation and injection
12. Endothelial relaxant factor in the human epicardial coronary artery
13. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries